Clinical Trial

KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury

Study acronym: KALM-B
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A study looking at the safety and tolerability of KAP (Ketamine-Assisted Psychotherapy) in the burn population.
Trial Details
NCT Number NCT07563296
Lead Sponsor Irma Fleming
Collaborators: University of Utah
Conditions PTSD and Trauma-related Symptoms
Enrollment 12 participants
Start Date 2026-04-01
Primary Completion 2027-12-01 (estimated)
Study Completion 2028-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-04